Cargando…
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
Various papers have introduced the use of positron emission tomography (PET) with [(68)Ga]Ga-radiolabeled fibroblast-activation protein inhibitor (FAPi) radiopharmaceuticals in different subtypes of gastric cancer (GC). Our aim was to assess the diagnostic performance of this novel molecular imaging...
Autores principales: | Rizzo, Alessio, Racca, Manuela, Garrou, Federico, Fenocchio, Elisabetta, Pellegrino, Luca, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Annunziata, Salvatore, Treglia, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299436/ https://www.ncbi.nlm.nih.gov/pubmed/37373285 http://dx.doi.org/10.3390/ijms241210136 |
Ejemplares similares
-
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
por: Rizzo, Alessio, et al.
Publicado: (2022) -
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023) -
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023) -
A Rare Case of Incidental Finding of Cervical Spinal Cord Hemangioblastoma by (68)Ga-DOTATOC Positron Emission Tomography/Computed Tomography Scan
por: Bellini, Pietro, et al.
Publicado: (2022) -
(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)